<DOC>
	<DOCNO>NCT00577330</DOCNO>
	<brief_summary>Myalgesin botanical preparation consist celery seed extract , extract dry Boswellia serrata , dry extract Phellodendron bark . Component extract show exert anti-inflammatory effect inhibit cyclooxygenase 5-lipooxygenase . The study base hypothesis oral administrration botanical support joint function people osteoarthritis knee improve symptom mobility measure Western Ontario McMaster Universities ( WOMAC ) Osteoarthritis Index .</brief_summary>
	<brief_title>Efficacy Myalgesin™ Support Joint Function Patients With Knee Osteoarthritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Men woman age 50years old . Patients symptomatic osteoarthritis knee define American College Rheumatology criterion ( traditional format ) . At least moderate pain knee ( rat 40 great subject visual analogue scale ) day last month . Use analgesic antiinflammatory agent control pain least 1 month . Baseline functional capacity class 1 3 , class 1 complete ability carry usual activity without handicap , class 2 ability adequately conduct usual activity despite handicap discomfort limit mobility one joint , class 3 limited ability carry usual activity . ( American Rheumatism Association functional class ) Documented radiographic change osteoarthritis previous knee radiograph ( KellgrenLawrence grade 2 ) . Age &lt; 50years . Body mass index ( BMI ) equal great 35 kg/m2 . Baseline functional class 4 subject bedridden confine wheelchair , largely wholly incapacitate capable little selfcare . ( American Rheumatism Association functional class ) Inflammatory arthritis , gout , pseudogout , Paget 's disease . Presence chronic pain syndrome , fibromyalgia reflex sympathetic dystrophy , may interfere assessment joint symptomatology . Severe bursitis knee . History acute joint trauma within 30 day study entry . Complete loss articular cartilage . History total knee replacement . Intraarticular/intramuscular corticosteroid within 30 day study entry . Intraarticular hyaluronan hyalans within 30 day study entry . History gastrointestinal bleeding within 1 year study entry . Active peptic ulcer disease , gastroesophageal reflux disease , inflammatory bowel disease . Gastrointestinal tract ulceration within 30 day study entry . Severe renal dysfunction define serum creatinine great 2 mg/dL . Clinically significant liver disease include aspartate aminotransferase alanine aminotransferase &gt; 2 time upper limit normal . Unwillingness inability abstain ethanol study duration . Significant bleed disorder . History gastric duodenal surgery . Warfarin use . Sensitivity acetaminophen component Myalgesin™ . Pregnancy . Any serious medical , social psychological condition , opinion Principal Investigator , would disqualify subject participation .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>